Towards precision medicine for cancer patient stratification (Supervisor: Anagha Joshi)
On average, a drug or a treatment is effective in only about half of patients who take it. This means patients need to try several until they find one that is effective at the cost of side effects associated with every treatment. The ultimate goal of precision medicine is to provide a treatment best suited for every individual. Sequencing technologies have now made genomics data available in abundance to be used towards this goal.
In this project we will specifically focus on cancer. Most cancer patients get a particular treatment based on the cancer type and the stage, though different individuals will react differently to a treatment. It is now well established that genetic mutations cause cancer growth and spreading and importantly, these mutations are different in individual patients. The aim of this project is use genomic data allow to better stratification of cancer patients, to predict the treatment most likely to work. Specifically, the project will use machine learning approach to integrate genomic data and build a classifier for stratification of cancer patients.
Unraveling gene regulation from single cell data (Supervisor: Anagha Joshi)
Multi-cellularity is achieved by precise control of gene expression during development and differentiation and aberrations of this process leads to disease. A key regulatory process in gene regulation is at the transcriptional level where epigenetic and transcriptional regulators control the spatial and temporal expression of the target genes in response to environmental, developmental, and physiological cues obtained from a signalling cascade. The rapid advances in sequencing technology has now made it feasible to study this process by understanding the genomewide patterns of diverse epigenetic and transcription factors as well as at a single cell level.
Single cell RNA sequencing is highly important, particularly in cancer as it allows exploration of heterogenous tumor sample, obstructing therapeutic targeting which leads to poor survival. Despite huge clinical relevance and potential, analysis of single cell RNA-seq data is challenging. In this project, we will develop strategies to infer gene regulatory networks using network inference approaches (both supervised and un-supervised). It will be primarily tested on the single cell datasets in the context of cancer.
For additional projects please contact the research group leaders directly: https://www.cbu.uib.no/research.